Inflammatory pathways in cervical cancer - The University of Cape Town's contribution

South African Medical Journal

Volumn 102, Issue 6, 2012, Pages 493-496

  Sales, Kurt J ^a   Katz, Arieh A ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOPOIETIN; CHEMOKINE; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; G PROTEIN COUPLED RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; MATRIX METALLOPROTEINASE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E; PROSTANOID G PROTEIN COUPLED RECEPTOR; PROSTANOID G PROTEIN COUPLED RECEPTOR 2; PROSTANOID G PROTEIN COUPLED RECEPTOR 4; UNCLASSIFIED DRUG; VASCULOTROPIN; WART VIRUS VACCINE; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE;

ARTICLE; CARCINOGENESIS; CHLAMYDIA TRACHOMATIS; DISEASE COURSE; HIGH RISK POPULATION; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; NEISSERIA GONORRHOEAE; NONHUMAN; PAPILLOMAVIRUS INFECTION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEMINAL PLASMA; TUMOR GROWTH; UTERINE CERVICITIS; UTERINE CERVIX CANCER; WART VIRUS; FEMALE; IMMUNOLOGY; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PAPILLOMA VIRUS; REVIEW; SIGNAL TRANSDUCTION; SOUTH AFRICA; SPERM; UNIVERSITY; UTERINE CERVIX TUMOR;

FEMALE; HUMANS; INFLAMMATION; NEOVASCULARIZATION, PATHOLOGIC; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; SEMEN; SIGNAL TRANSDUCTION; SOUTH AFRICA; UNIVERSITIES; UTERINE CERVICAL NEOPLASMS;

EID: 84865109259     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Arbyn M, Castellsague X, de Sanjose S, et al. Worldwide burden of cervical cancer in 2008. Ann Oncol 2011;22(12):2675-2686.
2. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127(12):2893-2917.
3. zur Hausen H. Papillomaviruses in the causation of human cancers-a brief historical account. Virology 2009;384:260-265.
4. Stanley MA, Pett MR, Coleman N. HPV: from infection to cancer. Biochem Soc Trans 2007;35:1456-1460.
5. Kemp TJ, Hildesheim A, Garcia-Pineres A, et al. Elevated systemic levels of inflammatory cytokines in older women with persistent cervical human papillomavirus infection. Cancer Epidemiol Biomarkers Prev 2010;19:1954-1959.
6. Jabbour HN, Sales KJ, Catalano RD, Norman JE. Inflammatory pathways in female reproductive health and disease. Reproduction 2009;138:903-919.
7. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-867.
8. Oh JM, Kim SH, Lee YI, et al. Human papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-dependent pathways in cervical cancer cells. Carcinogenesis 2009;30:141-149.
9. Bodily J, Laimins LA. Persistence of human papillomavirus infection: keys to malignant progression. Trends Microbiol 2011;19:33-39.
10. Pahler JC, Tazzyman S, Erez N, et al. Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response. Neoplasia 2008;10:329-340.
11. Subbaramaiah K, Dannenberg AJ. Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange. Cancer Res 2007;67:3976-3985.
12. Sales KJ, Jabbour HN. Cyclooxygenase enzymes and prostaglandins in reproductive tract physiology and pathology. Prostaglandins Other Lipid Mediat 2003;71:97-117.
13. Sales KJ, Katz AA, Davis M, et al. Cyclooxygenase-2 expression and prostaglandin E(2) synthesis are up-regulated in carcinomas of the cervix: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors. J Clin Endocrinol Metab 2001; 86:2243-2249.
14. Sales KJ, Katz AA, Howard B, et al. Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin e receptors, and angiogenic factors by cyclooxygenase-1. Cancer Res 2002;62:424-432.
15. Santin AD, Zhan F, Bignotti E, et al. Gene expression profiles of primary HPV16-and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy. Virology 2005;331:269-291.
16. Sales KJ, Katz AA, Millar RP, Jabbour HN. Seminal plasma activates cyclooxygenase-2 and prostaglandin E2 receptor expression and signalling in cervical adenocarcinoma cells. Mol Hum Reprod 2002;8:1065-1070.
17. Muller M, Sales KJ, Katz AA, Jabbour HN. Seminal plasma promotes the expression of tumorigenic and angiogenic genes in cervical adenocarcinoma cells via the E-series prostanoid 4 receptor. Endocrinology 2006;147:3356-3365.
18. Mazibrada J, Ritta M, Mondini M, et al. Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis. Gynecol Oncol 2008;108:112-120.
19. Tavares-Murta BM, Mendonca MA, Duarte NL, et al. Systemic leukocyte alterations are associated with invasive uterine cervical cancer. Int J Gynecol Cancer 2010;20:1154-1159.
20. da Silva Cardeal LB, Brohem CA, Corrêa TC, et al. Higher expression and activity of metalloproteinases in human cervical carcinoma cell lines is associated with HPV presence. Biochem Cell Biol 2006;84:713-719.
21. Duffy CL, Phillips SL, Klingelhutz AJ. Microarray analysis identifies differentiation-associated genes regulated by human papillomavirus type 16 E6. Virology 2003;314:196-205.
22. Fung KY, Glode LM, Green S, Duncan MW. A comprehensive characterization of the peptide and protein constituents of human seminal fluid. Prostate 2004;61:171-181.
23. Sharkey DJ, Tremellen KP, Jasper MJ, Gemzell-Danielsson, Robertson SA. Seminal fluid induces leukocyte recruitment and cytokine and chemokine mRNA expression in the human cervix after coitus. J Immunol 2012 (in press).
24. Jeremias J, Witkin SS. Effect of human seminal fluid on production of messenger ribonucleic acid for metalloproteinase 2 and metalloproteinase 9 in cervical epithelial carcinoma cells. Am J Obstet Gynecol 1999;181:591-595.
25. Burn J, Gerdes AM, Macrae F, et al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet 2011;378(9809):2081-2087.